FDA Inspection 1257010 — Overton Brooks VA Medical Center
The FDA completed an inspection of Overton Brooks VA Medical Center on December 18, 2024 in Shreveport, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 18, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shreveport, LA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 22733 | FDCA 501(a)(2)(A) | Beta-lactam, hazardous, highly potent drugs, prevention of cross-contamination |
| 22740 | FDCA 501(a)(2)(A) | Personnel infrequently, changed/sanitized gloves |
| 22769 | FDCA 501(a)(2)(A) | Media fills, failure |